Back to search

Interaction of calcium antagonists with cyclic AMP phosphodiesterases and calmodulin

Data up to Jan 2025

Published1982
Citations163
References27

Total Citations Per Year

Abstract

References (27)

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1970 • 253,849 citations

The Determination of Enzyme Dissociation Constants

1934 • 11,865 citations

The determination of enzyme inhibitor constants

1953 • 4,050 citations

Specific Pharmacology of Calcium in Myocardium, Cardiac Pacemakers, and Vascular Smooth Muscle

1977 • 1,745 citations

Verapamil

1978 • 829 citations

Calcium Channel Blocking Agents in the Treatment of Cardiovascular Disorders. Part II: Hemodynamic Effects and Clinical Applications

1980 • 551 citations

Calcium-induced exposure of a hydrophobic surface on calmodulin

1980 • 520 citations

Conformational transition accompanying the binding of calcium(2+) ion to the protein activator of 3',5'-cyclic adenosine monophosphate phosphodiesterase

1977 • 472 citations

Hydrophobic regions function in calmodulin-enzyme(s) interactions.

1980 • 363 citations

New Perspectives on Calcium Antagonists

1982 • 310 citations

Purification of plant calmodulin by fluphenazine-Sepharose affinity chromatography

1979 • 252 citations

Interaction of the antihypertensive drug felodipine with calmodulin

1981 • 251 citations

Cyclic Nucleotide Phosphodiesterases: Properties, Activators, Inhibitors, Structure–Activity Relationships, and Possible Role in Drug Development

1975 • 206 citations

A 113Cd NMR study of calmodulin and its interaction with calcium, magnesium and trifluoperazine

1980 • 127 citations

Effects of N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide and other calmodulin antagonists (calmodulin interacting agents) on calcium-induced contraction of rabbit aortic strips.

1981 • 116 citations

Cyclic adenosine 3':5'-monophosphate phosphodiesterase. Distinct forms in human lymphocytes and monocytes.

1976 • 90 citations

Inhibition of cyclic amp phosphodiesterase by 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-[2-(N-benzyl-N-methylamino)] ethyl ester 5-methyl ester hydrochloride (YC-93), a potent vasodilator

1978 • 83 citations

Purification and characterization of high-affinity cyclic adenosine monophosphate phosphodiesterase from dog kidney

1979 • 81 citations

Stimulation of enzyme activities by fragments of calmodulin

1981 • 75 citations

Selective inhibition of cyclic nucleotide phosphodiesterases by analogs of 1-methyl-3-isobutylxanthine

1977 • 74 citations

REGULATION OF MYOSIN LIGHT CHAIN KINASE BY REVERSIBLE PHOSPHORYLATION AND CALCIUM‐CALMODULIN

1980 • 60 citations

Proceedings of the British Pharmacological Society

1979 • 54 citations

Effects of nifedipine, a potent calcium-antagonistic coronary vasodilator, on atrioventricular conduction and blood flow in the isolated atrioventricular node preparation of the dog

1975 • 32 citations

Increased cyclic nucleotide phosphodiesterase activity associated with proliferation and cancer in human and murine lymphoid cells.

1977 • 32 citations

Dihydro- and tetrahydroisoquinolines as inhibitors of cyclic nucleotide phosphodiesterases from dog heart

1979 • 30 citations

Differential regulation of calcium-dependent and calcium-independent cyclic nucleotide phosphodiesterases from heart by palmitoylcarnitine and palmitoyl coenzyme A

1982 • 15 citations

Calcium Entry Blockers in Cardiologic Therapy

1981 • 10 citations

Cited By (0)

Loading...
Interaction of calcium antagonists with cyclic AMP phosphodiesterases and calmodulin (1982) – Biochemical and Biophysical Research Communications | Metascience Observatory Explorer